Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2200 of 3173 entries
View as:

A Study To Evaluate The PDE10 Enzyme Occupancy Following A Single Dose Of PF-02545920 In Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01918202 Org: User:
Start: 03/31/14 End: 09/30/14 Due: 09/30/15

Long Term Use of Somavert (Pegvisomant) For A Regulatory Post Marketing Commitment Plan

Phase: N/A Priority: Normal
NCT ID: NCT00658879 Org: User:
Start: 08/07/07 End: 11/09/16 Due: 11/09/17

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib

Phase: N/A Priority: Normal
NCT ID: NCT00548093 Org: User:
Start: 04/29/08 End: 06/11/12 Due: 06/11/13

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00920816 Org: User:
Start: 08/25/09 End: 04/29/21 Due: 04/29/22

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00712504 Org: User:
Start: 07/31/04 End: 11/30/07 Due: 11/30/08

A Study of PF-06410293 Following Subcutaneous Administration Using A Prefilled Syringe Or A Prefilled Pen In Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02572245 Org: User:
Start: 01/31/16 End: 05/31/16 Due: 05/31/17

A 2-part Study to Assess Local Tolerability, Safety and Pharmacokinetics of Ceftaroline in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01577589 Org: User:
Start: 04/30/12 End: 09/30/12 Due: 09/30/13

Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00683137 Org: User:
Start: 10/31/02 End: 02/28/03 Due: 02/28/04

Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg

Phase: N/A Priority: Normal
NCT ID: NCT00195338 Org: User:
Start: 05/31/04 End: 12/31/10 Due: 12/31/11

Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00641225 Org: User:
Start: 03/31/08 End: 03/31/11 Due: 03/31/12

Efficacy And Safety Of Azithromycin SR Compared With Minocycline In Acne

Phase: N/A Priority: Normal
NCT ID: NCT00392223 Org: User:
Start: 10/31/07 End: 06/30/08 Due: 06/30/09

A Study to Describe Treatment Patterns of Advanced Breast Cancer in Poland in the Real-world Data Setting

Phase: N/A Priority: Normal
NCT ID: NCT05478590 Org: User:
Start: 11/22/21 End: 09/30/22 Due: 09/30/23

A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT02057341 Org: User:
Start: 02/28/14 End: 05/31/16 Due: 05/31/17

MEK162 for Patients With RAS/RAF/MEK Activated Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01885195 Org: User:
Start: 10/10/13 End: 04/11/17 Due: 04/11/18

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00003720 Org: User:
Start: 07/31/98 End: - Due: -

A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life.

Phase: N/A Priority: Normal
NCT ID: NCT00549055 Org: User:
Start: 11/30/07 End: 10/31/09 Due: 10/31/10

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

Phase: N/A Priority: Normal
NCT ID: NCT02952586 Org: User:
Start: 11/28/16 End: 08/25/20 Due: 08/25/21

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

Phase: N/A Priority: Normal
NCT ID: NCT00161863 Org: User:
Start: 09/30/02 End: 01/31/03 Due: 01/31/04

A Study to Determine the Effects of PF-04965842 on Midazolam PK in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03647670 Org: User:
Start: 07/03/18 End: 10/16/18 Due: 10/16/19

Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01121562 Org: User:
Start: 07/31/10 End: 11/30/13 Due: 11/30/14

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children

Phase: N/A Priority: Normal
NCT ID: NCT00174473 Org: User:
Start: 06/30/03 End: 08/31/05 Due: 08/31/06

Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India

Phase: N/A Priority: Normal
NCT ID: NCT04541706 Org: User:
Start: 08/27/20 End: 07/20/22 Due: 07/20/23

Conversion to Embeda With Rescue Trial

Phase: N/A Priority: Normal
NCT ID: NCT01179191 Org: User:
Start: 08/31/10 End: 04/30/11 Due: 04/30/12

Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02007512 Org: User:
Start: 12/16/13 End: 08/23/24 Due: 08/23/25

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

Phase: N/A Priority: Normal
NCT ID: NCT05207865 Org: User:
Start: 03/15/22 End: 07/02/24 Due: 07/02/25